In our study, we observed that overexpression of miR‐503 increased the expression of TGF‐β and CTGF in CFs, an effect that was abolished by the co‐application of Apelin‐13. The gene discussed is CCN2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.